The Shares of Nutrition 21, Inc. (NasdaqCM: NXXI) were Up Sharply Tuesday 5.13%; as the Company is Set to Present at the RedChip Small Cap Conference
Nutrition 21, Inc. is Set to Present at the RedChip Small Cap Conference Next Month in New York City. The Company is involved in research and product development aimed to help diabetics. Recently, Nutrition 21, Inc. (NASDAQ: NXXI) announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome®, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs). Patients in the treatment group showed significant improvements in glycemic control (A1C) compared with placebo (an absolute decrease…